Welcome to Primus Diagnostics, a Trinity Biotech Company… supplying the global marketplace with the most clinically useful A1c (glycohemoglobin) methods and the most comprehensive assay system for aid in identification and quantitation of A2, F and Hb variants.

Interference-free affinity based methodology coupled with analytical precision give healthcare providers the unbeatable combination of speed and accuracy in glycohemoglobin testing.

An innovator in hemoglobin variant testing, thalassemias and newborn screening, Primus offers superior separations and the automatic reflex of samples with suspected variants from a quick-scan to a high-resolution method.

 

Primus…when the right answer is the only answer.